InvestorsHub Logo
Post# of 24977
Next 10
Followers 1
Posts 68
Boards Moderated 1
Alias Born 02/11/2004

Re: None

Thursday, 11/16/2006 10:32:19 AM

Thursday, November 16, 2006 10:32:19 AM

Post# of 24977
buying ICGN at .75

icgn trading below cash at .76 cents way to cheap listen to the cc they are working with the fda on the trial where the stock got hit earlier in the year , small float 17m for a bio stock


PRODUCT PIPELINE http://www.icagen.com/about/productpipeline.html


The Company’s four most advanced programs are:

ICA-17043 for sickle cell disease, for which the Company is conducting a Phase III clinical trial;

lead compounds for epilepsy and neuropathic pain, for which the Company is conducting preclinical studies;

a compound for atrial fibrillation, for which the Company’s collaborator Bristol-Myers Squibb Company is conducting preclinical studies; and

lead compounds for dementia, including Alzheimer’s disease, for which the Company’s collaborator Astellas Pharma Inc. is conducting preclinical studies, and lead compounds for attention deficit/hyperactivity disorder, which were derived from the collaboration and for which the Company is conducting preclinical studies.

Icagen is also conducting ongoing drug discovery programs focused on new therapeutics for pain disorders, inflammatory disorders and glaucoma.


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.